Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development
- 1 June 2004
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (6) , 354-362
- https://doi.org/10.1016/s1470-2045(04)01492-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Alterations of the p16INK4 locus in human malignant mesothelial tumorsCarcinogenesis: Integrative Cancer Research, 2002
- Apoptosis: A Link between Cancer Genetics and ChemotherapyPublished by Elsevier ,2002
- Bcl-x Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial MembraneJournal of Biological Chemistry, 2001
- Phase II Study of Vinorelbine in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2000
- Apoptosis in developmentNature, 2000
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Simian virus-40 large-T antigen binds p53 in human mesotheliomasNature Medicine, 1997
- The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomasNature Medicine, 1997
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972